Bolt Biotherapeutics, Inc. (BOLT) Total liabilities 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) total liabilities at each fiscal year-end, per SEC filings.
$30.2MFY2025 · since FY2020: $46.2M → $30.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $30.2M | -28.7% |
| FY2024 | $42.4M | -9.8% |
| FY2023 | $47.0M | -16.4% |
| FY2022 | $56.3M | -2.3% |
| FY2021 | $57.6M | +24.7% |
| FY2020 | $46.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice